Protective Mechanical Ventilation and Risk of Postoperative Complications in Abdominal Surgery
NCT ID: NCT03165760
Last Updated: 2017-05-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2015-07-01
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Intraoperative PEEP Individualization According to Driving Pressure in Major Abdominal Surgery
NCT05781373
Intraoperative Protective Ventilation and Postoperative Pulmonary Complications
NCT02671721
Ventilation Strategies Impact on Oxygenation and Postoperative Pulmonary Complications in Lung Surgery Patients
NCT06805760
Lung-protective Mechanical Ventilation for Abdominal Laparoscopic Surgeries
NCT04546932
Individualized Perioperative Open Lung Ventilatory Strategy
NCT02158923
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients were not included if they had specially acute respiratory disease, severe asthma or emphysema, sleep apnea syndrome, septic shock and body mass index (BMI) \< 16 or \> 35 Kg/m2. Participants were excluded in case of serious peroperative anesthetic complications or hemorrhagic shock.
Primary endpoint was postoperative pulmonary complications occurring within the first 7 days after surgery (defined as hypoxemia, Broncho-pneumopathy, pulmonary infiltrate, acute respiratory distress syndrome, atelectasis, pleural effusion).
Secondary endpoints for all participants were intra-operative complications (change in SpO2 when dropped less than 90%, hypotension \<90 mmHg lasting more than 3 min, need for vasopressor administration, new arrhythmia), postoperative extrapulmonary complications (septic shock, postoperative surgical complications, heart disease complications). Investigators recorded for all participants length of hospital stay and mortality rate were .
Investigators randomly allocated patients before entering to the operating room to:
* Control Group (CG): patients ventilated with Vt of 8 ml/kg of predicted body weight (PBW), a low level of PEEP (4 cm H2O) without RM.
* Protective Ventilation Group (PVG): patients ventilated with a low Vt of 6 ml/Kg of PBW, a high level of PEEP (10 cm H2O), RMs applied after intubation, before extubation and in case of disconnection from the ventilator.
Other ventilation settings, type of anesthesia, fluid administration and post operative pain management were standardized.
In the postoperative period, investigators daily assessed clinical examination and arterial blood gas if pulse oximetry dropped. For all participants, a chest X ray, blood count creatinine and C reactive protein were done at day 1 and day 3.
Data were presented as means and standard deviation \[SD\] or frequencies. Statistical analyses were performed using SPSS statistical software version 20.0. A p-value of 0.05 was considered significant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control group
Vt = 8 ml/kg of PBW and PEEP = 4 cm H2O
No interventions assigned to this group
protective ventilation group
Vt = 6ml/kg of PBW, PEEP = 10 and RM if disconnected
protective ventilation
the aim of the intervention is to ovoid Ventilator induced lung injury and inflammatory stress
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
protective ventilation
the aim of the intervention is to ovoid Ventilator induced lung injury and inflammatory stress
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mongi Slim Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mhamed Sami Mebazaa
professor head of the anesthesiology-ICU departement
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Mongi Slim OR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.